| 摘要 |
An anti-inflammatory pharmaceutical formulation for the oral administration of a nonsteroidal anti-inflammatory drug (NSAID) is provided, wherein the NSAID an anti-inflammatory naphthalene derivative such as nabumetone, 6-methoxy-2-naphthylacetic acid (6-MNA), a fluoronaphthylone, an amido-substituted naphthalene compound, or a nabumetone derivative comprising an acetal, enol acylate or enol ether of nabumetone. The formulation is controlled release, and a preferred formulation is an enterically coated, delayed release dosage form of nabumetone. Methods for using the novel formulation are provided as well; a preferred use is in the treatment of conditions and disorders associated with inflammation.
|
